AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 6814596
Drug: Transaxial tomoscintigraphy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transaxial tomoscintigraphy using iodine‐131‐labelled monoclonal antibodies against carcinoembryonic antigen
Trial: 18042798
Drug: Steroids alone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Steroids alone
Trial: 25529014
Drug: High-dose chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose chemotherapy (HI-CT)
Trial: 1312233
Drug: Lisinopril +
RxNorm normalized name: Lisinopril
DrugBank: Lisinopril (DB00722)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lisinopril + Hydrochlorothiazide (LIS + HCTZ)
Trial: 3900906
Drug: Calf lung
RxNorm normalized name: Calf lung surfactant extract (CLSE)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calf lung surfactant extract (3 mL, 90 mg) instilled into trachea before the first breath
Trial: 27055228
Drug: Low-level laser
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-level laser therapy (LLLT) using a 660-nm laser (200 mW, 6 J per point at 4 points) and an 810-nm laser (200 mW, 6 J per point at 3 points) applied on days 2 and 4 after surgery
Trial: 25646296
Drug: Azilsartan 20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Azilsartan 20 mg
Trial: 17943639
Drug: Desmopressin tablets
RxNorm normalized name: desmopressin Sublingual Tablet
DrugBank: Desmopressin (DB00035)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Desmopressin tablets and nasal spray
Trial: 25213159
Drug: Medication plus
RxNorm normalized name: salicylic acid Medicated Shampoo [Ionil Plus]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medication plus supportive care
Trial: 14741163
Drug: ALVAC-HIV vaccines
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ALVAC-HIV vaccines
Trial: 14741163
Drug: ALVAC-HIV vaccines
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ALVAC-HIV vaccines with recombinant envelope subunit vaccine
Trial: 10052667
Drug: Noradrenaline infusion
RxNorm normalized name: noradrenaline hydrochloride
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Noradrenaline infusion for 1 hour
Trial: 28689794
Drug: SQ grass
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SQ grass sublingual immunotherapy tablet
Trial: 23913463
Drug: SIELLO T
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SIELLO T steroid‐eluting ventricular leads
Trial: 23913463
Drug: SIELLO JT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SIELLO JT steroid‐eluting atrial leads
Trial: 23913463
Drug: BPPU T
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BPPU T non‐steroid leads
Trial: 23913463
Drug: BPPU JT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BPPU JT non‐steroid leads
Trial: 12579548
Drug: Self-administered psychosocial
RxNorm normalized name: corticotropin
DrugBank: Corticotropin (DB01285)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Self-administered psychosocial treatments (manual- and multimedia-based treatments)
Trial: 12579548
Drug: Self-administered psychosocial
RxNorm normalized name: corticotropin
DrugBank: Corticotropin (DB01285)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Self-administered psychosocial treatments (inspirational literature and support groups)
Trial: 10731864
Drug: Ferrous sulfate
RxNorm normalized name: Ferrous Sulfate
DrugBank: Ferrous fumarate (DB14491)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ferrous sulfate (1 mg/kg/d) (Group B)
Trial: 12969204
Drug: Caffeine citrate
RxNorm normalized name: Caffeine Citrate
DrugBank: Caffeine (DB00201)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Caffeine citrate 3 mg/kg
Trial: 3527997
Drug: Arginine tidiacicate
RxNorm normalized name: arginine tidiacicate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Arginine tidiacicate (ATCA) at a dose of 400 mg tablets three times a day for 30 days
Trial: 2659736
Drug: Cyclosporin (mean
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cyclosporin (mean dose 7.2 mg/kg/day)
Trial: 2659736
Drug: Cyclosporin (mean
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cyclosporin (mean dose 5 mg/kg/day)
Trial: 24420962
Drug: THC/CBD spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: THC/CBD spray
Trial: 12151445
Drug: Highly purified
RxNorm normalized name: RAYON,PURIFIED
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Highly purified urinary FSH (150 IU starting dose)
Trial: 12151445
Drug: Clomiphene citrate
RxNorm normalized name: Clomiphene Citrate
DrugBank: Clomifene (DB00882)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Clomiphene citrate (100 mg/day from day 5-10 of the ovarian cycle)
Trial: 12151445
Drug: FSH after
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FSH after failure with CC
Trial: 12151445
Drug: CC followed
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: CC followed by FSH if pregnancy not obtained
Trial: 9471040
Drug: Casodex 50
RxNorm normalized name: Casodex 50mg Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Casodex 50 mg daily
Trial: 30897305
Drug: Ibuprofen lysinate
RxNorm normalized name: Ibuprofen Lysine
DrugBank: Ibuprofen (DB01050)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Ibuprofen lysinate (postprandial)
Trial: 8614572
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg ritanserin
Trial: 10803508
Drug: Initial systemic
RxNorm normalized name: brigatinib
DrugBank: Brigatinib (DB12267)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Initial systemic chemotherapy (prednisone, vincristine, doxorubicin, cyclophosphamide)
Trial: 8628601
Drug: Antenatal phenobarbital
RxNorm normalized name: Phenobarbital
DrugBank: Phenobarbital (DB01174)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antenatal phenobarbital (PB) therapy
Trial: 8628601
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no PB therapy)
Trial: 29754812
Drug: Continued medical
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continued medical therapy (control, n=86)
Trial: 25590178
Drug: Somatostatin 250μg
RxNorm normalized name: Somatostatine
DrugBank: Somatostatin (DB09099)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Somatostatin 250μg bolus injection before ERCP and 250μg/hour intravenous infusion for 11 hours after ERCP
Trial: 22790176
Drug: VRET with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: VRET with cognitive therapy
Trial: 20564068
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg of oral modafinil daily
Trial: 16301017
Drug: Psychological treatments
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Psychological treatments (behavioural, cognitive-behavioural, cognitive)
Trial: 23663490
Drug: Pharmacological treatments
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pharmacological treatments
Trial: 3923855
Drug: Disodium cromoglycate
RxNorm normalized name: Disodium cromoglycate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Disodium cromoglycate (DSCG) 20 mg inhaled four times a day for 2 months
Trial: 3923855
Drug: Ketotifen 1
RxNorm normalized name: ketotifen 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketotifen 1 mg orally twice a day for 2 months
Trial: 3923855
Drug: Clemastine 1
RxNorm normalized name: clemastine 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clemastine 1 mg orally twice a day for 1 week
Trial: 3923855
Drug: Placebo (lactose)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (lactose) capsule twice a day for 2 months
Trial: 31469914
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of micro-needling (MN) and 5-aminolevulinic acid photodynamic therapy (ALA-PDT) in Group-C (17 patients)
Trial: 25794468
Drug: Weekly bisphosphonate
RxNorm normalized name: methylene diphosphonate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Weekly bisphosphonate (alendronate or risedronate)
Trial: 25794468
Drug: Monthly bisphosphonate
RxNorm normalized name: methylene diphosphonate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Monthly bisphosphonate (minodronate)
Trial: 23096041
Drug: Adaptol, 25-35
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adaptol, 25-35 mg/kg for 1-3 months
Trial: 10228375
Drug: Placebo cream
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo cream (applied to contralateral sites)
Trial: 7699214
Drug: Dexamethasone (DXM,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexamethasone (DXM, 1 mg orally overnight)
Trial: 7699214
Drug: Loperamide (LOP,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Loperamide (LOP, 16 mg orally)
Trial: 2740833
Drug: Folic acid
RxNorm normalized name: Folic Acid
DrugBank: Folic acid (DB00158)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Folic acid supplementation (5 mg Folacin) for 1 year
Trial: 30851062
Drug: evolocumab 140
RxNorm normalized name: evolocumab 140 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: evolocumab 140 mg every 2 weeks (Q2W)
Trial: 30851062
Drug: evolocumab 420
RxNorm normalized name: evolocumab 420 in 3.5 ML Cartridge
FDA approved: no
EMA approved: no
PMDA approved: no
Description: evolocumab 420 mg monthly (QM)
Trial: 15201943
Drug: Anakinra (interleukin-1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anakinra (interleukin-1 receptor antagonist)
Trial: 9035511
Drug: Nucleus CMP
RxNorm normalized name: Sus scrofa thalamus lateral geniculate nucleus preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nucleus CMP forte (dysodic cytidinmonophosphate 5 mg, trisodic uridintriphosphate 3 mg, hydroxicobalamin 2 mg) tid for six months
Trial: 3866536
Drug: 400 mg
RxNorm normalized name: mesna 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 mg slow-release pentoxifylline tablets ('Trental 400') twice a day for one week, followed by three times daily for seven weeks
Trial: 1837120
Drug: LO‐Tact‐1 (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LO‐Tact‐1 (10 mg i.v. per day) with cyclosporin (8 mg/kg/day), low‐dose steroids (1/2 mg/kg/day), and azathioprine (1 mg/kg/day starting at day 45)
Trial: 1837120
Drug: Cyclosporin, high‐dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cyclosporin, high‐dose steroids (2 mg/day at day 1), and a 14‐day course of polyclonal horse antilymphocyte globulins (ALG)
Trial: 1837120
Drug: LO‐Tact‐1 treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LO‐Tact‐1 treatment
Trial: 1837120
Drug: Cyclosporin, high‐dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cyclosporin, high‐dose steroids, and ALG
Trial: 82030
Drug: Continuous levamisole
RxNorm normalized name: Levamisole
DrugBank: Levamisole (DB00848)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Continuous levamisole treatment
Trial: 82030
Drug: Intermittent levamisole
RxNorm normalized name: Levamisole
DrugBank: Levamisole (DB00848)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intermittent levamisole treatment
Trial: 31160080
Drug: Polytetrafluoroethylene strips
RxNorm normalized name: polytetrafluoroethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Polytetrafluoroethylene strips as an adjunct to epinephrine‐impregnated gauze (test group, n = 15)
Trial: 28452620
Drug: Intensive periodontal
RxNorm normalized name: lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intensive periodontal therapy for 4 weeks
Trial: 22085402
Drug: 0.1 mol/L
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.1 mol/L hydrochloric acid infusion
Trial: 19308439
Drug: Thermal water
RxNorm normalized name: thermal water
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thermal water with negligible radon content (6 Bq/l) for 15 days
Trial: 17308218
Drug: Oral prednisolone
RxNorm normalized name: prednisolone Oral Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral prednisolone 15 mg/day
Trial: 11577835
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg alteplase (15 mg as bolus, followed by an infusion of 35 mg over 60 min) plus tirofiban (0.4 mcg/kg/min for 30 min followed by an infusion of 0.1 mcg/kg/min for 3 days)
Trial: 3323074
Drug: Ceftazidime 3
RxNorm normalized name: ceftazidime 30 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ceftazidime 3 perioperative 1 g intramuscular doses every 6 h (group B)
Trial: 24834773
Drug: Sublingual immunotherapy
RxNorm normalized name: Adoptive immunotherapy agent CTL019
DrugBank: Tisagenlecleucel (DB13881)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sublingual immunotherapy (SLIT) with Pru p 3-enriched peach extract
Trial: 18457717
Drug: Percutaneous treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Percutaneous treatment with distal protection
Trial: 15670265
Drug: Education and
RxNorm normalized name: zinc pyrithione Medicated Shampoo [Free and Clear]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Education and biofeedback (BF) therapy
Trial: 12200980
Drug: 6 mg/kg/24
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6 mg/kg/24 h ferrous sulphate given orally for 3 months
Trial: 22587485
Drug: LED therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LED therapy
Trial: 22587485
Drug: Neuromuscular electrical
RxNorm normalized name: methyl salicylate
DrugBank: Methyl salicylate (DB09543)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Neuromuscular electrical stimulation and laser therapy
Trial: 22587485
Drug: Neuromuscular electrical
RxNorm normalized name: methyl salicylate
DrugBank: Methyl salicylate (DB09543)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Neuromuscular electrical stimulation and LED therapy
Trial: 17724210
Drug: Topical clonidine
RxNorm normalized name: clonidine Topical Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical clonidine
Trial: 15038091
Drug: LPZ(60 mg/d)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LPZ(60 mg/d) alone
Trial: 15038091
Drug: LPZ(60 mg/d)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LPZ(60 mg/d) with CAM(400 mg/d) and AMPC(1,500 mg/d)
Trial: 15038091
Drug: LPZ(60 mg/d)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LPZ(60 mg/d) with CAM(800 mg/d) and AMPC(1,500 mg/d)
Trial: 7982254
Drug: Ampicillin/sulbactam (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ampicillin/sulbactam (1 to 2 g ampicillin and 0.5 to 1 g sulbactam, administered intravenously once every 6 hours)
Trial: 2600246
Drug: 10-week group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10-week group treatment program
Trial: 31518550
Drug: Normal placental
RxNorm normalized name: human placental tissue preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Normal placental growth factor (>100 pg/mL)
Trial: 31518550
Drug: Placental growth
RxNorm normalized name: RECOMBINANT HUMAN PLACENTAL GROWTH FACTOR
DrugBank: Recombinant human placental growth factor (PLGF-131) (DB18586)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placental growth factor ≤100 pg/mL
Trial: 31518550
Drug: Placental growth
RxNorm normalized name: RECOMBINANT HUMAN PLACENTAL GROWTH FACTOR
DrugBank: Recombinant human placental growth factor (PLGF-131) (DB18586)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placental growth factor <12 pg/mL
Trial: 31518550
Drug: Placental growth
RxNorm normalized name: RECOMBINANT HUMAN PLACENTAL GROWTH FACTOR
DrugBank: Recombinant human placental growth factor (PLGF-131) (DB18586)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placental growth factor 12-100 pg/mL
Trial: 24960095
Drug: Deep oscillation
RxNorm normalized name: Deep Sea
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Deep oscillation treatment applied for at least one week following the operation.
Trial: 24960095
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no deep oscillation treatment).
Trial: 14987329
Drug: 3 x
RxNorm normalized name: Xenon (133 xe)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 x 60 mg orlistat
Trial: 14987329
Drug: 3 x
RxNorm normalized name: Xenon (133 xe)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 x 120 mg orlistat
Trial: 29991700
Drug: High-dose chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose chemotherapy with autologous stem cell transplantation (ASCT)
Trial: 2736420
Drug: 0.25 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.25 mg/kg etomidate (group II; n = 6)
Trial: 2736420
Drug: 0.5 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 mg/kg etomidate (group III; n = 6)
Trial: 22177541
Drug: Pre-operative fluid
RxNorm normalized name: lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pre-operative fluid loading with 25 ml/kg of Ringer's solution in the six hours before surgery
Trial: 19818722
Drug: 11-valent pneumococcal
RxNorm normalized name: Streptococcus pneumoniae serotype 10A capsular antigen diphtheria CRM197 protein conjugate vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 11-valent pneumococcal protein D conjugate vaccine
Trial: 10489822
Drug: Montelukast 10
RxNorm normalized name: montelukast 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Montelukast 10 mg
Trial: 16513447
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of telithromycin and montelukast
Trial: 15568664
Drug: Complex drug
RxNorm normalized name: hesperidin complex
DrugBank: Citrus bioflavonoids (DB14586)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Complex drug and laser therapy
Trial: 9381027
Drug: Cognex (donepezil)
DrugBank: Tacrine (DB00382)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cognex (donepezil) treatment, specific dosage and duration not mentioned
Trial: 1948791
Drug: Inhaled PGE2
RxNorm normalized name: PGE2
DrugBank: Dinoprostone (DB00917)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Inhaled PGE2 (100 micrograms)
Trial: 29536252
Drug: Bupivacaine 0.5%
RxNorm normalized name: BUPivacaine 0.5% injectable kit
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bupivacaine 0.5% administered for local wound infiltration
Trial: 9503259
Drug: Clozapine treatment
RxNorm normalized name: Clozapine
DrugBank: Clozapine (DB00363)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Clozapine treatment (24 +/- 15 months prior to study)
Trial: 9503259
Drug: Clozapine treatment
RxNorm normalized name: Clozapine
DrugBank: Clozapine (DB00363)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Clozapine treatment (6 weeks)
Trial: 3732427
Drug: 0.2 mg
RxNorm normalized name: niacin 0.2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.2 mg of fenoterol in powder form
Trial: 3732427
Drug: 0.2 mg
RxNorm normalized name: niacin 0.2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.2 mg of fenoterol in MDI form
Trial: 28188479
Drug: Normal weight
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Normal weight control group (no treatment)
Trial: 8351679
Drug: Ethyl biscoumacetate
RxNorm normalized name: Ethyl biscoumacetate
DrugBank: Ethyl biscoumacetate (DB08794)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ethyl biscoumacetate (300 mg) alone
Trial: 26437311
Drug: 10 session
RxNorm normalized name: AVOBENZONE 30 mg in 1 mL / HOMOSALATE 100 mg in 1 mL / OCTISALATE 50 mg in 1 mL / OCTOCRYLENE 60 mg in 1 mL TOPICAL LOTION [SESSION SAVERS SUNSCREEN BROAD SPECTRUM SPF 30 WATER RESISTANT]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 session cognitive behavioral therapy (IPaViT‐CBT) group intervention
Trial: 24176784
Drug: Kundalini Yoga
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Kundalini Yoga Therapy
Trial: 24176784
Drug: Yoga Therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Yoga Therapy Adapted for Older Veterans
Trial: 24176784
Drug: Yoga Therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Yoga Therapy
Trial: 16542200
Drug: Tiotropium bromide
RxNorm normalized name: Tiotropium Bromide
DrugBank: Tiotropium (DB01409)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tiotropium bromide 54 mcg
Trial: 16542200
Drug: Ipratropium bromide
RxNorm normalized name: Ipratropium Bromide
DrugBank: Ipratropium (DB00332)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ipratropium bromide 40 mcg
Trial: 10634377
Drug: Metformin (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin (500 mg tid)
Trial: 19018143
Drug: Doubling the
RxNorm normalized name: THE-630
DrugBank: THE-630 (DB16750)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Doubling the dose of low-, medium-, and high-potency statins
Trial: 2202901
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg of beta carotene per day
Trial: 29409133
Drug: Secukinumab 300
RxNorm normalized name: secukinumab 300 MG in 2 ML Auto-Injector
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Secukinumab 300 mg and 150 mg
Trial: 17668973
Drug: SRP plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SRP plus 25% metronidazole gel
Trial: 2452564
Drug: Prourokinase (7.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prourokinase (7.5 mg bolus + 66.5 mg infusion over 60 minutes)
Trial: 2452564
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of prourokinase (3.7 mg bolus + 250,000 IU urokinase + 44.3 mg prourokinase)